Missed this exciting update in neurodegenerative drug development? 🧠✨ In their recent article, Certara's Hugo Geerts, Piet Van Der Graaf, Silke Bergeler from BMS, and SUNY professor, William Lytton explore the challenges of neurodegenerative diseases, marked by scarce biomarkers and subjective assessments. Their breakthrough? Integrating Computational Neurosciences' predictions with QSP's insights, boosting success rates in drug development. Read more about how this methodology paves the way for innovative therapeutic interventions: https://ow.ly/FpIp50Q0huT #Neuroscience #DrugDevelopment #ComputationalModeling #QSP
